E-Scopics has secured FDA 510(k) clearance for its new Hepatoscope-Derived Fat Fraction (HDFF) technology, combining ultrasound attenuation with backscattering coefficient to measure liver fat. With a documented high correlation to MRI-PDFF, this innovation promises broader access to non-invasive fatty liver assessment.

Pro Football Hall of Famer Dan Marino speaks candidly about his 2007 MASH diagnosis and why he is eager to share his health story. Through a new partnership with Novo Nordisk, he hopes to raise greater awareness about the importance of fatty liver disease management.